関連する実験動画
Updated: Mar 18, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.7K
ヒトメラノーマとT細胞の相互作用中のネオアンチゲン景観のダイナミクス
Nature
|June 29, 2016
まとめ
癌の免疫療法は ネオアンチゲンの認識に依存しています この研究では,腫瘍はこれらのネオアンチゲンを失いますが,T細胞は適応し,抵抗を防ぐために広範なT細胞反応の必要性を強調しています.
科学分野:
- 免疫学
- 腫瘍学
- 遺伝学
背景:
- DNAの損傷から生じるネオアンチゲンは T細胞チェックポイントブロックや 採用T細胞治療のような癌の免疫療法にとって重要な標的である.
- 腫瘍の抗原性はT細胞の圧力によって変化し,臨床前モデルで認識された変異抗原の喪失につながる可能性があります.
- ネオアンチゲン特異のT細胞応答とヒトがんにおけるその標的の安定性は,時間の経過とともにほとんど特徴づけられていない.
研究 の 目的:
- 新抗原特異性T細胞の反応と彼らが認識する抗原の安定性を研究する.
- ネオアンチゲン認識と潜在的な免疫脱出機構の文脈における腫瘍細胞とT細胞のダイナミックな相互作用を理解する.
主な方法:
- ステージIVのメラノーマの患者2人の新抗原特異性T細胞応答とその認識された抗原の分析.
- T細胞が認識した新抗原に関連した遺伝子発現と変異性アレル喪失を含む腫瘍細胞集団の変化の評価.
- ネオアンチゲン喪失への反応として,腫瘍に浸透するリンパ球内のT細胞の反応性の評価.
主要な成果:
- T細胞で認識されたネオアンチゲンは,研究された患者の腫瘍細胞集団から選択的に失われました.
- ネオアンチゲンの喪失は,遺伝子発現の減少または変異性アレルの喪失によって発生した.
- ネオアンチゲンの喪失は,腫瘍に浸透したリンパ球内のネオアンチゲン特異のT細胞反応性の発達と関連していた.
結論:
- T細胞はネオアンチゲン免疫編集の形態を介し,がん細胞とダイナミックに相互作用する.
- 腫瘍細胞は標的ネオアンチゲンを失って T細胞の認識を回避します
- 治療戦略は,腫瘍抵抗を克服し,免疫脱出を防ぐために,広範な新抗原特異のT細胞反応を誘導することを目指すべきである.
関連する概念動画
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment
3.0K
3.0K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells
4.2K
4.2K
T Cell Activation and Clonal Selection
17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Antigens Involved in Adaptive Immunity
1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K

